MarketInOut Stock Screener Log In | Sign Up

Bio-Gene Technology Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 14:16
Bio-Gene Technology Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization7.45 mln
Float394 mln
Earnings Date03/03/2027

Piotroski F-Score

3 / 9
Below average

Relative Strength

6 / 100
Severely lagging

ROE

-143
Deeply negative

ROA

-112
Deeply negative

Business Description

Bio-Gene Technology Limited is a Melbourne-based company founded in 1995 that develops and sells insecticide products made from natural sources, serving markets in Australia and around the world. Its two main products are Flavocide, a lab-made compound that mirrors a naturally occurring substance, and Qcide, an oil extracted from plants and rich in tasmanone. The company works with a wide network of research partners, including universities, government agencies, and scientific institutions, to test and refine its products across uses such as crop protection, grain storage, animal health, and public health.

Key Fundamentals

EPS-0.01
ROE-143
RPS0.00
ROIC-638
ROA-112
EBITDA, mln-2.76
EV / EBITDA-1.52
EV / EBIT-1.49
Revenue, mln1.08
EV / Revenue5.11

Quote Details

Last 0.013
Change -0.004 (-23.53%)
Open 0.013
Volume 55,000
Turnover 715
Average Volume 328,463

Financial Ratios

Leverage Ratio1.25
Current Ratio4.78
Price / Book3.20
Price / Tangible Book1.70

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 58 / 100   
1 Month -27.78% 7 / 100   
2 Months -35% 9 / 100   
6 Months -69.05% 2 / 100   
1 Year -31.58% 28 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog